The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma

Fei-Xiang Wu,Jie Chen,Tao Bai,Shao-Liang Zhu,Tian-Bo Yang,Lu-Nan Qi,Ling Zou,Zi-Hui Li,Jia-Zhou Ye,Le-Qun Li

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma

2017

Fei-Xiang Wu
Jie Chen
Tao Bai
Shao-Liang Zhu
Tian-Bo Yang
Lu-Nan Qi
Ling Zou
Zi-Hui Li
Jia-Zhou Ye
Le-Qun Li

Background Sorafenib and transarterial chemoembolization (TACE) are recommended therapies for advanced hepatocellular carcinoma (HCC), but their combined efficacy remains unclear.

Keywords:

Pathology
BCLC Stage
Medicine
Hepatocellular carcinoma
Oncology
Internal medicine
Adverse effect
Sorafenib
Surgical oncology
baseline data
mean age
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations